Grant: Catalyst Grant - Mild Traumatic Brain Injury
Université Laval
$99,247.00
Refinement of a clinical decision rule for comprehensive assessment and early detection of patients at risk of persistent symptoms following a mild traumatic brain injury
EF 2012-13
Résumé
Cerebral concussions are a common and they can affect anyone. Some populations are more at risk especially teenagers and young male adults. In Canada, about 500-650/100 000 people sustain a mild cerebral concussion (Mild Traumatic Brain Injury) and it is suspected that many of them do not even seek medical attention.
The management of these patients varies a lot (i.e. according to geographical regions). Most of the data regarding mild cerebral concussion is based on expert opinion. Those patients are rarely admitted and conducting robust and structured studies recruiting a large cohort of patients is difficult. Moreover, many patients are at risk of developing persistent symptoms for more than three months after the trauma (between 10 and 40 %). It is crucial to target those patients and to monitor them closely. Because of a lack of scientific evidence, no guideline has been proposed for the detection of those at-risk patients. There is an urgent need for physicians and nurses in the Emergency Department to have access to a simple, quick, and reliable clinical decision rule, which could predict if complications/persistent symptoms are to be expected.
Five teaching hospitals in Quebec are already working together to develop tools to better predict the evolution and prognosis of patients with mild cerebral concussions. Our previous studies have identified significant risk factors for developing persistent symptoms three months after the injury and we have suggested some predictive models. However, these models are solely based on clinical factors (i.e. age, post-traumatic amnesia, etc) and do not seem to identify high-risk patients specifically enough. Along with this, none of the different biomarkers (i.e. protein S100B) studied so far can predict patient evolution on their own. We think that a model integrating clinical criteria AND biomarker(s) will help better identify patients at risk for persistent symptoms three months after their concussion.
Programme
Catalyst Grant - Mild Traumatic Brain Injury
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
270330
Name
Le Sage Natalie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Department of National Defence R&D
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Mild Traumatic Brain Injury
Projecttitle
Refinement of a clinical decision rule for comprehensive assessment and early detection of patients at risk of persistent symptoms following a mild traumatic brain injury
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$99,247
Cihrequipment2
$0
Programname2
Catalyst Grant - Mild Traumatic Brain Injury
Keyworddelim
Biomarqueurs; Outil D'Évaluation; Pronostic; Stratification; Traumatisme Cranio-Cérébral Léger
Abstract
Cerebral concussions are a common and they can affect anyone. Some populations are more at risk especially teenagers and young male adults. In Canada, about 500-650/100 000 people sustain a mild cerebral concussion (Mild Traumatic Brain Injury) and it is suspected that many of them do not even seek medical attention.
The management of these patients varies a lot (i.e. according to geographical regions). Most of the data regarding mild cerebral concussion is based on expert opinion. Those patients are rarely admitted and conducting robust and structured studies recruiting a large cohort of patients is difficult. Moreover, many patients are at risk of developing persistent symptoms for more than three months after the trauma (between 10 and 40 %). It is crucial to target those patients and to monitor them closely. Because of a lack of scientific evidence, no guideline has been proposed for the detection of those at-risk patients. There is an urgent need for physicians and nurses in the Emergency Department to have access to a simple, quick, and reliable clinical decision rule, which could predict if complications/persistent symptoms are to be expected.
Five teaching hospitals in Quebec are already working together to develop tools to better predict the evolution and prognosis of patients with mild cerebral concussions. Our previous studies have identified significant risk factors for developing persistent symptoms three months after the injury and we have suggested some predictive models. However, these models are solely based on clinical factors (i.e. age, post-traumatic amnesia, etc) and do not seem to identify high-risk patients specifically enough. Along with this, none of the different biomarkers (i.e. protein S100B) studied so far can predict patient evolution on their own. We think that a model integrating clinical criteria AND biomarker(s) will help better identify patients at risk for persistent symptoms three months after their concussion.
Competitiondate
201210
Approvedterm2
1 yr 0 mth
Pinamesdelim
Le Sage, Natalie
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Gender & Health~ $62,300~ $0~Inst of Neurosc Mental Hlth &A~ $36,947~ $0~